One of the modality in handling Covid-19 in Indonesia is using rapid antigen test and/or rapid antibody test. Rapid tests are only early screening process, which have to re-confirm with RT-PCR.
Rapid Antibody tests are widely used for people who will do domestic travel activities.
Rapid antibody test can be done at a Health Care Facilitiy or outside a Health Care Facilitiy as long as being carried out by Health Worker.
Price varies on the rapid test examination causing public confusion. Government role is needed in rapid test examination tariff matter to ensure public not being exploited for profit.
This circular letter is intended to give public and rapid test examination services certainty, so that the existing tariff can provides guarantee for the public on rapid antibody test easy access service.
Complete document content can be found here: